Peter Hedlin
About
In The Last Decade
Peter Hedlin
15 papers receiving 257 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 134
- Molecular Medicine 91
- Molecular Biology 69
- Epidemiology 59
- Ophthalmology 53
Countries citing papers authored by Peter Hedlin
This map shows the geographic impact of Peter Hedlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hedlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hedlin more than expected).
Fields of papers citing papers by Peter Hedlin
This network shows the impact of papers produced by Peter Hedlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hedlin. The network helps show where Peter Hedlin may publish in the future.
Co-authorship network of co-authors of Peter Hedlin
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hedlin. A scholar is included among the top collaborators of Peter Hedlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hedlin. Peter Hedlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 10 | |
| 7 | 27 | |
| 8 | 11 | |
| 9 | The Antimicrobial Activity of Gatifloxcin (GAT) With or Without Benzalkonium Chloride (BAK) Against Ocular Bacterial Pathogens | 4 |
| 10 | Comparative Minimal Inhibitory and Mutant Prevention Concentration (MPC) Of Gatifloxacin (GA) and Other Compounds Against Gram–Positive Ocular Pathogens | 2 |
| 11 | The Killing of Ocular Isolates of Pseudomonas aeruginosa (PA) and Klebsiella pneumoniae (KP) by Gatifloxacin (GA) – A New Fluoroquinolone (FQ). | 1 |
| 12 | Determination of Minimal Inhibitory Concentration (MIC) and Mutant Prevention Concentration (MPC) of Ocular Isolates of Pseudomonas aeruginosa (PA) and Haemophilus influenzae (HI) to 5 Fluorquinolone (FQ) Antimicrobial Agents (AA). | 2 |
| 13 | 94 | |
| 14 | 115 | |
| 15 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.